Jefferies boosted estimates and its price target on Sagent Pharmaceuticals (NASDAQ: SGNT) from $20 to $21 following strong Q1 results ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE